Chu R

No ORCID on file · 5 papers in corpus
observational 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02108-8

PURPOSE: Accurate prognostic prediction remains a significant challenge in the management of low-grade serous ovarian cancer (LGSOC), a rare and molecularly distinct histologic subtype. This study aimed to develop a prediction model visuali…

lab-animal 2026
Redox biology ·doi:10.1016/j.redox.2026.104101

Endometriosis (EM) is driven by immune dysregulation and macrophage dysfunction, yet the underlying mechanisms remain unclear. Here, metabolomic profiling revealed excessive itaconate accumulation in EM lesions, primarily due to elevated ci…

lab-animal 2023
Biomaterials research ·doi:10.1186/s40824-023-00442-2

BACKGROUND: Endometriosis is a common gynecological disease in women of childbearing age. Commonly used treatment methods, such as endocrine and surgical therapies, display poor therapeutic effects with a high relapse probability. Thus, nov…

review 2022
Pain and therapy ·doi:10.1007/s40122-022-00430-9

INTRODUCTION: Chronic pelvic pain (CPP) is a symptom that derives from a complex group of heterogeneous pathologies of the pelvic organs. The aim of this study was to review the available evidence on efficacy of neuromodulatory modalities i…

observational 2020
Frontiers in oncology ·doi:10.3389/fonc.2020.01353

Introduction: The International Federation of Gynecology and Obstetrics (FIGO) staging system is considered the most powerful prognostic factor in patients with cervical cancer. In addition, other surgical-pathological risk factors have bee…